S&K Polytec Balance Sheet Health
Financial Health criteria checks 4/6
S&K Polytec has a total shareholder equity of ₩117.9B and total debt of ₩92.7B, which brings its debt-to-equity ratio to 78.7%. Its total assets and total liabilities are ₩254.8B and ₩137.0B respectively. S&K Polytec's EBIT is ₩8.5B making its interest coverage ratio 2.9. It has cash and short-term investments of ₩70.1B.
Key information
78.7%
Debt to equity ratio
₩92.74b
Debt
Interest coverage ratio | 2.9x |
Cash | ₩70.13b |
Equity | ₩117.86b |
Total liabilities | ₩136.99b |
Total assets | ₩254.84b |
Recent financial health updates
These 4 Measures Indicate That S&K Polytec (KOSDAQ:091340) Is Using Debt Extensively
Aug 12These 4 Measures Indicate That S&K Polytec (KOSDAQ:091340) Is Using Debt Extensively
Mar 08We Think S&K Polytec (KOSDAQ:091340) Is Taking Some Risk With Its Debt
Nov 23Recent updates
These 4 Measures Indicate That S&K Polytec (KOSDAQ:091340) Is Using Debt Extensively
Aug 12S&K Polytec Co., Ltd.'s (KOSDAQ:091340) Share Price Boosted 30% But Its Business Prospects Need A Lift Too
May 30Returns On Capital Signal Difficult Times Ahead For S&K Polytec (KOSDAQ:091340)
May 21These 4 Measures Indicate That S&K Polytec (KOSDAQ:091340) Is Using Debt Extensively
Mar 08Here's What To Make Of S&K Polytec's (KOSDAQ:091340) Returns On Capital
Feb 01Investors Who Bought S&K Polytec (KOSDAQ:091340) Shares Five Years Ago Are Now Up 45%
Dec 28We Think S&K Polytec (KOSDAQ:091340) Is Taking Some Risk With Its Debt
Nov 23Financial Position Analysis
Short Term Liabilities: A091340's short term assets (₩155.8B) exceed its short term liabilities (₩123.5B).
Long Term Liabilities: A091340's short term assets (₩155.8B) exceed its long term liabilities (₩13.5B).
Debt to Equity History and Analysis
Debt Level: A091340's net debt to equity ratio (19.2%) is considered satisfactory.
Reducing Debt: A091340's debt to equity ratio has reduced from 109.4% to 78.7% over the past 5 years.
Debt Coverage: A091340's debt is not well covered by operating cash flow (1.4%).
Interest Coverage: A091340's interest payments on its debt are not well covered by EBIT (2.9x coverage).